课题基金 / 基金详情

Medical reversals: De-implementing ineffective and unsafe treatments

Medical reversals: De-implementing ineffective and unsafe treatments
医疗逆转:取消无效和不安全治疗的实施
批准号:
9753151
负责人:
PINAR KARACA-MANDIC
金额:
$33.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2021-07-31

项目摘要

项目成果

PINAR KARACA-MANDIC的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
Abstract Understanding whether and how robust clinical evidence is integrated into practice is critical from the perspectives of: a) improving patient safety and health outcomes; b) designing programs and policies to accelerate the use of high value, effective treatments and abandon less effective and harmful treatments; c) containing health care costs by allocating limited health care budgets to their most effective use. In most circumstances, physicians and health care delivery organizations (HCDOs) are the key agents in determining whether a patient receives a given medical treatment. However, physician and HCDO integration of clinical evidence into practice is not well studied or understood. In general, the term “integration of evidence into practice”, could mean both the adoption of new treatments and de-implementation of established treatments based on new evidence related to effectiveness or safety. In this proposal, we will focus on the latter. Our primary focus is to understand how physician networks, HCDOs and physician market environment influence the de-implementation of ineffective and unsafe treatments in practice. As such, we have the following aims: Aim 1: To describe variation in the de-implementation of ineffective and unsafe treatments across physicians and HCDOs. Aim 2: To investigate how characteristics of the physician (i.e. age, gender, years since medical school or residency, patient-mix), HCDO (i.e. practice size, specialty mix, ownership, level of integration), physician's patient sharing network (i.e. betweenness centrality), and physician's market environment (competition, malpractice environment) influence de-implementation of ineffective and unsafe treatments by physicians. Aim 3: To assess the influence of de-implementation of ineffective or unsafe treatments in the physicians' network (defined by HCDO affiliation and patient-sharing) on physicians' likelihood to de-implement ineffective and unsafe treatments. We will focus on different case studies concerning treatments with implications for cardiovascular outcomes and safety. Our study sample will include the Medicare Fee-For Service (FFS) population (from CMS) as well as the commercially insured and Medicare Advantage (MA) populations (OptumLabs).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid learning during a public health emergency: COVID-19 related medication treatment patterns in Medicare
  • 批准号:
    10711497
  • 项目类别:
  • 资助金额:
    $39.97万
  • 财政年份:
    2023
  • 负责人:
    PINAR KARACA-MANDIC
  • 依托单位:
Physician Level Analysis of Medical Technology Diffusion: Coronary Stents Study
  • 批准号:
    8530134
  • 项目类别:
  • 资助金额:
    $12.39万
  • 财政年份:
    2010
  • 负责人:
    PINAR KARACA-MANDIC
  • 依托单位:
Physician Level Analysis of Medical Technology Diffusion: Coronary Stents Study
  • 批准号:
    8721292
  • 项目类别:
  • 资助金额:
    $12.39万
  • 财政年份:
    2010
  • 负责人:
    PINAR KARACA-MANDIC
  • 依托单位:
Physician Level Analysis of Medical Technology Diffusion: A Study of Coronary Ste
  • 批准号:
    8043966
  • 项目类别:
  • 资助金额:
    $12.1万
  • 财政年份:
    2010
  • 负责人:
    PINAR KARACA-MANDIC
  • 依托单位:
海外基金